XML 152 R30.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Measurements The following table summarizes our investments that are recognized in our consolidated balance sheets at December 31 using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by consolidated sponsored investment products which are presented separately on our consolidated balance sheets and are detailed in Note 6.
20232022
(in millions)Level 1Level 2Level 3Level 1Level 2Level 3
T. Rowe Price investment products
Cash equivalents held in money market funds$1,678.1 $— $— $1,412.0 $— $— 
Discretionary investments246.4 — — 242.0   
Seed capital206.0 41.8 — 161.0 34.1 — 
Supplemental savings plan liability economic hedges806.6 — — 760.7 — — 
Other investments0.7 — — 0.6 0.1 — 
Investments in affiliated collateralized loan obligations— 8.4 — — 6.4 — 
Total$2,937.8 $50.2 $— $2,576.3 $40.6 $— 
Contingent consideration liability$— $— $13.4 $— $— $95.8 
Schedule of Change in Contingent Consideration Liability
The change in the contingent consideration liability measured at fair value for which we used Level 3 inputs to determine fair value is as follows:

Year-ended
(in millions)
 12/31/2023
 12/31/2022
Balance at beginning of the year$95.8 $306.3 
Measurement period adjustment— (49.3)
Unrealized gains, included in earnings(82.4)(161.2)
Balance at end of the year$13.4 $95.8